Tissue Graft Maker MiMedx Settles False Claims Pricing Suit For $6.5M

Mealey's (April 17, 2020, 5:22 PM EDT) -- MINNEAPOLIS — Biopharmaceutical company MiMedx Group Inc. has agreed to pay $6.5 million to settle a false claims lawsuit that it charged inflated prices to the Department of Veterans Affairs (VA) for tissue graft products, according to an April 6 stipulation and to announcements by the U.S. Justice Department and the company (United States ex rel. Jess Kruchoski, et al. v. MiMedx Group, Inc., No. 17-187, D. Minn.)....

Attached Documents

Related Sections